Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DRIO Stock Summary
Top 10 Correlated ETFs
DRIO
In the News
DRIO Financial details
Company Rating
Neutral
Market Cap
36.21M
Income
726.06K
Revenue
20.35M
Book val./share
2.14
Cash/share
1.36
Dividend
-
Dividend %
-
Employees
276
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
510.82
Forward P/E
-
PEG
-50.89
P/S
2.25
P/B
0.83
P/C
0.89
P/FCF
-1.68
Quick Ratio
6.21
Current Ratio
6.93
Debt / Equity
0.49
LT Debt / Equity
0.42
-
-
EPS (TTM)
0.01
EPS next Y
-
EPS next Q
-
EPS this Y
-26.62%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-24.45%
Revenue last 5Y
21.91%
Revenue Q/Q
2.79%
EPS Q/Q
-174.58%
-
-
-
-
SMA20
-17.83%
SMA50
-35.5%
SMA100
21.7%
Inst Own
21.79%
Inst Trans
0.66%
ROA
-
ROE
-
ROC
-0.52%
Gross Margin
36%
Oper. Margin
-217%
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.68-4.58
52W High
-
52W Low
-
RSI
38.42
Rel Volume
0.44
Avg Volume
137.49K
Volume
59.91K
Perf Week
-15.38%
Perf Month
-27.98%
Perf Quarter
-41.26%
Perf Half Y
-54.51%
-
-
-
-
Beta
1.656
-
-
Volatility
0.1%, 0.16%
Prev Close
3.42%
Price
1.21
Change
5.22%
DRIO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.34 | 1.27 | 1.24 | 1.17 | 0.72 | |
Net income per share | -7.84 | -4.86 | -4.63 | -2.63 | -1.93 | |
Operating cash flow per share | -6.94 | -2.97 | -3.04 | -2.02 | -1.07 | |
Free cash flow per share | -6.98 | -2.99 | -3.05 | -2.05 | -1.09 | |
Cash per share | 9 | 4.79 | 2.16 | 2.09 | 1.31 | |
Book value per share | 8.34 | 4.72 | 5.16 | 3.38 | 2.05 | |
Tangible book value per share | 8.34 | 4.72 | 1.9 | 1.2 | 0.39 | |
Share holders equity per share | 8.34 | 4.72 | 5.16 | 3.38 | 2.05 | |
Interest debt per share | 0.35 | 0.1 | 0.02 | 1.27 | 1.01 | |
Market cap | 14.87M | 85.22M | 215.19M | 101.16M | 48.8M | |
Enterprise value | -4.76M | 57.16M | 179.67M | 79.85M | 41.25M | |
P/E ratio | -0.84 | -2.94 | -2.8 | -1.63 | -0.89 | |
Price to sales ratio | 1.97 | 11.25 | 10.49 | 3.66 | 2.4 | |
POCF ratio | -0.95 | -4.8 | -4.27 | -2.11 | -1.61 | |
PFCF ratio | -0.94 | -4.77 | -4.25 | -2.09 | -1.58 | |
P/B Ratio | 0.79 | 3.03 | 2.52 | 1.26 | 0.84 | |
PTB ratio | 0.79 | 3.03 | 2.52 | 1.26 | 0.84 | |
EV to sales | -0.63 | 7.54 | 8.76 | 2.89 | 2.03 | |
Enterprise value over EBITDA | 0.27 | -1.9 | -2.46 | -1.52 | -0.81 | |
EV to operating cash flow | 0.3 | -3.22 | -3.56 | -1.67 | -1.36 | |
EV to free cash flow | 0.3 | -3.2 | -3.55 | -1.65 | -1.33 | |
Earnings yield | -1.2 | -0.34 | -0.36 | -0.61 | -1.12 | |
Free cash flow yield | -1.06 | -0.21 | -0.24 | -0.48 | -0.63 | |
Debt to equity | 0.04 | 0.02 | 0 | 0.35 | 0.49 | |
Debt to assets | 0.03 | 0.02 | 0 | 0.24 | 0.3 | |
Net debt to EBITDA | 1.12 | 0.93 | 0.49 | 0.41 | 0.15 | |
Current ratio | 4.39 | 4.85 | 3.17 | 3.39 | 3.77 | |
Interest coverage | -655.74 | -610.27 | -910.64 | -30.28 | 0 | |
Income quality | 0.89 | 0.6 | 0.66 | 0.77 | 0.55 | |
Dividend Yield | 0 | 0 | 0 | 0.24 | 0 | |
Payout ratio | 0 | 0 | 0 | -0.38 | 0 | |
Sales general and administrative to revenue | 0.73 | 1.68 | 1.15 | 0.6 | 0.89 | |
Research and developement to revenue | 0.49 | 0.59 | 0.84 | 0.71 | 0.99 | |
Intangibles to total assets | 0 | 0 | 0.54 | 0.43 | 0.49 | |
Capex to operating cash flow | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
Capex to revenue | -0.01 | -0.02 | -0.01 | -0.02 | -0.03 | |
Capex to depreciation | -0.54 | -0.62 | -0.08 | -0.12 | -0.11 | |
Stock based compensation to revenue | 0.3 | 1.47 | 1.22 | 0.61 | 0.97 | |
Graham number | 38.35 | 22.72 | 23.17 | 14.16 | 9.44 | |
ROIC | -0.87 | -1.01 | -0.89 | -0.52 | -0.64 | |
Return on tangible assets | -0.72 | -0.82 | -1.64 | -0.92 | -1.11 | |
Graham Net | 7.04 | 3.98 | 1.51 | 0.82 | 0.14 | |
Working capital | 17.72M | 27.09M | 31.23M | 46.17M | 34.6M | |
Tangible asset value | 18.89M | 28.15M | 31.45M | 28.44M | 11.1M | |
Net current asset value | 17.26M | 26.87M | 30.38M | 26.33M | 8.85M | |
Invested capital | 0.04 | 0.02 | 0 | 0.35 | 0.49 | |
Average receivables | 473K | 1.21M | 1.75M | 4.46M | 5.27M | |
Average payables | 2.12M | 2.07M | 3.79M | 3.72M | 1.73M | |
Average inventory | 1.4M | 1.85M | 4.26M | 7.09M | 6.51M | |
Days sales outstanding | 34.38 | 82.1 | 31.78 | 94.21 | 61.07 | |
Days payables outstanding | 121.81 | 178.79 | 112.68 | 47.08 | 28.73 | |
Days of inventory on hand | 104.01 | 165.31 | 137.35 | 161.32 | 128.59 | |
Receivables turnover | 10.62 | 4.45 | 11.49 | 3.87 | 5.98 | |
Payables turnover | 3 | 2.04 | 3.24 | 7.75 | 12.7 | |
Inventory turnover | 3.51 | 2.21 | 2.66 | 2.26 | 2.84 | |
ROE | -0.94 | -1.03 | -0.9 | -0.78 | -0.94 | |
Capex per share | -0.04 | -0.02 | -0.02 | -0.02 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.26 | 0.26 | 0.22 | 0.12 | 0.13 | |
Net income per share | -0.49 | 0.45 | -0.59 | 0.59 | -0.44 | |
Operating cash flow per share | -0.31 | -0.17 | -0.34 | -0.3 | -0.27 | |
Free cash flow per share | -0.31 | -0.18 | -0.35 | -0.31 | -0.27 | |
Cash per share | 1.92 | 1.56 | 1.87 | 1.52 | 1.36 | |
Book value per share | 3.11 | 2.61 | 2.78 | 2.36 | 2.14 | |
Tangible book value per share | 1.11 | 0.78 | 1.03 | 0.69 | 0.41 | |
Share holders equity per share | 3.11 | 2.61 | 2.78 | 2.36 | 2.14 | |
Interest debt per share | 1.13 | 1 | 1.07 | 1.04 | 1.07 | |
Market cap | 110.1M | 113.59M | 113.03M | 94.52M | 46.77M | |
Enterprise value | 88.79M | 101.17M | 90.55M | 80.56M | 39.22M | |
P/E ratio | -2.18 | 2.29 | -1.7 | 1.4 | -0.97 | |
Price to sales ratio | 16.17 | 16.08 | 18.37 | 26.87 | 12.93 | |
POCF ratio | -13.86 | -23.88 | -11.73 | -10.93 | -6.37 | |
PFCF ratio | -13.76 | -23.51 | -11.55 | -10.59 | -6.3 | |
P/B Ratio | 1.38 | 1.58 | 1.44 | 1.39 | 0.8 | |
PTB ratio | 1.38 | 1.58 | 1.44 | 1.39 | 0.8 | |
EV to sales | 13.04 | 14.32 | 14.72 | 22.9 | 10.85 | |
Enterprise value over EBITDA | -11.83 | -9.27 | -7.07 | -5.18 | -3.07 | |
EV to operating cash flow | -11.18 | -21.27 | -9.4 | -9.32 | -5.34 | |
EV to free cash flow | -11.1 | -20.94 | -9.26 | -9.03 | -5.28 | |
Earnings yield | -0.11 | 0.11 | -0.15 | 0.18 | -0.26 | |
Free cash flow yield | -0.07 | -0.04 | -0.09 | -0.09 | -0.16 | |
Debt to equity | 0.35 | 0.37 | 0.38 | 0.44 | 0.49 | |
Debt to assets | 0.24 | 0.24 | 0.26 | 0.28 | 0.3 | |
Net debt to EBITDA | 2.84 | 1.14 | 1.76 | 0.9 | 0.59 | |
Current ratio | 3.39 | 3.15 | 8.14 | 6.93 | 3.77 | |
Interest coverage | -9.93 | -11.57 | -876.25 | -675.91 | -25.29 | |
Income quality | 0.63 | 0.37 | 0.58 | 0.55 | 0.61 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.45 | 0.58 | 0.72 | 1.17 | 1.53 | |
Research and developement to revenue | 0.7 | 0.73 | 0.85 | 1.61 | 1.16 | |
Intangibles to total assets | 0.43 | 0.47 | 0.42 | 0.45 | 0.49 | |
Capex to operating cash flow | 0.01 | 0.02 | 0.02 | 0.03 | 0.01 | |
Capex to revenue | -0.01 | -0.01 | -0.02 | -0.08 | -0.02 | |
Capex to depreciation | -0.05 | -0.06 | -0.12 | -0.23 | -0.06 | |
Stock based compensation to revenue | 0.45 | 0.69 | 0.86 | 1.47 | 1.22 | |
Graham number | 5.86 | 5.14 | 6.07 | 5.58 | 4.61 | |
ROIC | -0.08 | 0.12 | -0.4 | -0.17 | -0.16 | |
Return on tangible assets | -0.19 | 0.22 | -0.24 | 0.29 | -0.24 | |
Graham Net | 0.76 | 0.53 | 0.78 | 0.45 | 0.14 | |
Working capital | 46.17M | 37.86M | 57.7M | 48.11M | 34.6M | |
Tangible asset value | 28.44M | 21.59M | 29.09M | 19.85M | 11.1M | |
Net current asset value | 26.33M | 19.5M | 27.02M | 17.74M | 8.85M | |
Invested capital | 0.35 | 0.37 | 0.38 | 0.44 | 0.49 | |
Average receivables | 6.85M | 6.21M | 6.07M | 6.67M | 4.94M | |
Average payables | 2.15M | 2.1M | 1.67M | 1.69M | 1.53M | |
Average inventory | 7.86M | 7.42M | 6.4M | 5.69M | 5.27M | |
Days sales outstanding | 94.35 | 67.26 | 100.47 | 165.44 | 84.75 | |
Days payables outstanding | 51.26 | 43.48 | 32.02 | 59.7 | 29.22 | |
Days of inventory on hand | 175.63 | 158.78 | 130.52 | 169.32 | 130.76 | |
Receivables turnover | 0.95 | 1.34 | 0.9 | 0.54 | 1.06 | |
Payables turnover | 1.76 | 2.07 | 2.81 | 1.51 | 3.08 | |
Inventory turnover | 0.51 | 0.57 | 0.69 | 0.53 | 0.69 | |
ROE | -0.16 | 0.17 | -0.21 | 0.25 | -0.21 | |
Capex per share | 0 | 0 | -0.01 | -0.01 | 0 |
DRIO Frequently Asked Questions
What is DarioHealth Corp. stock symbol ?
DarioHealth Corp. is a US stock , located in New york of Ny and trading under the symbol DRIO
What is DarioHealth Corp. stock quote today ?
DarioHealth Corp. stock price is $1.21 today.
Is DarioHealth Corp. stock public?
Yes, DarioHealth Corp. is a publicly traded company.